Cargando…
French Pharmacovigilance Public System and COVID-19 Pandemic
The current COVID-19 pandemic is an exceptional health situation including for drug use. As there was no known effective drug for COVID-19 at the beginning of the pandemic, different candidates were proposed. In this short article, we present the French public pharmacovigilance activities during thi...
Autores principales: | Grandvuillemin, Aurélie, Drici, Milou-Daniel, Jonville-Bera, Annie Pierre, Micallef, Joelle, Montastruc, Jean Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769328/ https://www.ncbi.nlm.nih.gov/pubmed/33372244 http://dx.doi.org/10.1007/s40264-020-01034-y |
Ejemplares similares
-
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023) -
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023) -
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021) -
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023) -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
por: Soeiro, Thomas, et al.
Publicado: (2021)